MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Why is Eli Lilly Betting on Shingles Vaccines

1 hour ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Why is Eli Lilly Betting Big on Orforglipron with a $1.5 Billion Inventory

3 months ago

Why Are Institutional Investors Still Bullish on Eli Lilly

2 months ago

What's Driving the Bearish Options Activity in Eli Lilly

2 months ago

Why Are Barclays Analysts Bullish on Eli Lilly and Bristol-Myers Squibb

2 months ago

Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine

Eli Lilly agreed to acquire a Bothell, Washington-based biotech firm for $1.5B to expand its vaccine pipeline. The deal focuses on developing a next-generation shingles vaccine, marking a significant ...

LLY

Stock News•6 days ago

Could Viking Therapeutics Be the Next Eli Lilly?

Viking Therapeutics is advancing weight loss candidates into late-stage clinical trials, positioning the firm to potentially challenge market leaders Eli Lilly and Novo Nordisk. The company's progress...

LLY

Stock News•1 week ago

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare leaders including Eli Lilly, Tandem Diabetes, Intuitive Surgical, and ResMed are targeting growth from aging-driven demand. These firms are focusing on obesity, surgical, and sleep care mar...

ABT

Stock News•3 weeks ago

Eli Lilly Stock Could Rise Sharply After Earnings

Eli Lilly shares have fallen over 20% since January, underperforming the broader market rally. The stock may face a bullish reversal post-earnings as high implied volatility unwinds and bearish option...

LLY